Adalimumab injection is a disease-modifying antirheumatic drug that works by inactivating tumor necrosis factors. Tumor necrosis factors cause body inflammation, and this drug helps to relieve its symptoms within 2 to 12 weeks. It is sold under the brand name Humira.
Adalimumab - Indications, Administration, Mechanism, and Adverse Effects
Adalimumab is an antibody used for rheumatoid arthritis, ankylosing spondylitis, and other inflammatory conditions. Read to know more about Adalimumab.
